Abstracts tagged "psoriatic arthritis and psoriasis"

Abstract Number: 1485 • 2019 ACR/ARP Annual Meeting
Secukinumab Provides Improvement in Nail Psoriasis and Inhibition of Radiographic Progression in Psoriatic Arthritis Patients with Nail Phenotype: 52-Week Results from a Phase III Study
Peter Nash¹, Philip Mease ², Bruce Kirkham ³, Alejandro Balsa ⁴, Atul Singhal ⁵, Erhard Quebe-Fehling ⁶, Luminita Pricop ⁷ and Corine Gaillez ⁶, ¹University of Queensland, Brisbane, Queensland, Australia, ²Swedish Medical Center/Providence St Joseph Health, and University of Washington, Seattle, WA, ³Guy's & St Thomas' NHS Foundation Trust, London, England, United Kingdom, ⁴Immuno-Rheumatology Research Group, IdiPaz & Rheumatology Department. La Paz University Hospital, Madrid, Spain, ⁵Southwest Rheumatology, Dallas, TX, ⁶Novartis Pharma AG, Basel, Switzerland, ⁷Novartis Pharmaceuticals Corporation, East Hanover, NJ
Background/Purpose: Nail psoriasis (PsO) is present in up to 80% in psoriatic arthritis (PsA) patients (pts) and associated with significant pain, psychosocial disability, decreased physical…
Abstract Number: 2456 • 2019 ACR/ARP Annual Meeting
Validity of Patient-reported Cardiovascular Events in a Large Longitudinal Cohort of Patients with Psoriatic Arthritis and Psoriasis
Keith Colaco¹, Vinod Chandran ², Dafna Gladman ³ and Lihi Eder ⁴, ¹University of Toronto, Women's College Hospital, University Health Network, Toronto, ON, Canada, ²University Health Network, University of Toronto, Toronto, Canada, ³Toronto Western Hospital, Toronto, Canada, Toronto, ON, Canada, ⁴Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada
Background/Purpose: Valuable information on cardiovascular disease outcomes can be obtained from large cohort studies. Such studies often rely on self-reported events, which are best validated…